CFTRinh-172
(Synonyms: CFTR(inh)172, Cystic Fibrosis Transmembrane Conductance Regulator Inhibitor 172) 目录号 : GC14421
CFTRinh-172被鉴定为囊性纤维化跨膜传导调节因子(CFTR)Cl-通道强效的选择性阻断剂。CFTRinh-172对野生型、G551D和G1349D CFTR的Cl-电流具有抑制作用，Ki值为0.5μM。
Cas No.:307510-92-5
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
CFTRinh-172 was identified as a potent and selective blocker of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel. CFTRinh-172 inhibits Cl- current in wild-type, G551D, and G1349D CFTR with Ki value of 0.5μM[1]. 1 and 10µM CFTRinh-172 caused 50% and 90% reduction of the original current in chinese hamster ovary (CHO) cells within 1-2s respectively with IC50 value of 1.1μM, and this inhibition is reversible[2].
In vitro, CFTR-expressing fischer rat thyroid cells incubated with CFTRinh-172 rapid and dose-dependently inhibited short-circuit current with CFTRinh-172 added to the solution bathing the apical cell surface. The average dose inhibition relationships of CFTRinh-172 is with Kd value of 300nM[3]. Human glioblastoma cell line U87 cells pretreated with CFTRinh-172 (5μM) for 30min, and then exposed to Forskolin (50μM) for additional 48h. CFTRinh-172 significantly increased cell viability and cell density, while partially restored inhibitory effects of Forskolin on U87 cell viability and cell density. CFTRinh-172 pretreatment partially attenuated the effects of Forskolin on Ki67 positive rate and significantly increased cell colony formation number[4]. CCRF-CEM, Jurkat and MOLT-4 T-ALL cell line were treated with CFTRinh-172 (5 to 40μM) for 24h or 48h. CFTRinh-172 concentration-dependently inhibited the growth of all three T-ALL cell lines and blocked the cell cycle. CCRF-CEM, JURKAT and MOLT-4 cells treated with 20μM CFTRinh-172 for 24h significantly changed the gene expression involved in various signaling pathways, including the Wnt/TGF-beta signaling pathway, the cell cycle, apoptotic process, cell proliferation, programmed cell death, etc[5].
In vivo, CFTRinh-172 (3mg/kg) was intraperitoneal administrated in E. coli-induced acute lung inflammation mouse models. Inhibition of CFTR by CFTRinh-172 deteriorated E. coli-induced acute lung inflammation. CFTRinh-172 induced deficiency of CFTR promotes migration of monocytes and neutrophils in E. coli pneumonia and peritonitis mouse models[6]. LPS-Induced Acute Lung Injury rat models were administrated with lipoxin A4 (2µM/kg; iv) following CFTRinh-172 treatment. 1.5mL (5mL/kg) of the instillate solution with CFTRinh-172 (1µM) was instilled at a rate of 0.08mL/min via tracheal instillation using a syringe pump. Lipoxin A4 significantly improved histology of rat lungs and inhibited IL-6 and TNF-α in LPS-induced lung injury. CFTRinh-172 abolished the effect of lipoxin A4 on alveolar fluid clearance (AFC)[7].
References:
[1] Taddei A, Folli C, Moran O G, et al. Altered channel gating mechanism for CFTR inhibition by a high-affinity thiazolidinone blocker. FEBS Lett. 2004 Jan 30;558(1-3):52-6.
[2] Kopeikin Z, Sohma Y, Li M, Hwang T C.On the mechanism of CFTR inhibition by a thiazolidinone derivative. J Gen Physiol. 2010 Dec;136(6):659-71.
[3] Ma T, Thiagarajah J R, Yang H, et al. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest. 2002 Dec;110(11):1651-8.
[4] Zhong X, Chen H Q, Yang X L, et al. CFTR activation suppresses glioblastoma cell proliferation, migration and invasion. Biochem Biophys Res Commun. 2019 Jan 22;508(4):1279-1285
[5] Liu M F, Liao H J, Chen Y, et al. Treatment of human T-cell acute lymphoblastic leukemia cells with CFTR inhibitor CFTRinh-172. Leuk Res. 2019 Nov:86:106225.
[6] Gao Z, Su X. CFTR regulates acute inflammatory responses in macrophages. QJM. 2015 Dec;108(12):951-8.
[7] Yang Y, Cheng Y, Lian Q Q, et al. Contribution of CFTR to alveolar fluid clearance by lipoxin A4 via PI3K/Akt pathway in LPS-induced acute lung injury. Mediators Inflamm. 2013:2013:862628.
CFTRinh-172被鉴定为囊性纤维化跨膜传导调节因子(CFTR)Cl-通道强效的选择性阻断剂。CFTRinh-172对野生型、G551D和G1349D CFTR的Cl-电流具有抑制作用，Ki值为0.5μM[1]。1μM和10μM的CFTRinh-172在1–2s内分别使中华仓鼠卵巢(CHO)细胞原始电流降低50%和90%，IC50值为1.1μM，且该抑制可逆[2]。
体外实验中，表达CFTR的Fischer大鼠甲状腺细胞经CFTRinh-172孵育后，可快速且剂量依赖性地抑制短路电流；CFTRinh-172被添加至细胞培养液中，平均剂量-抑制关系的Kd值为300nM[3]。人胶质母细胞瘤细胞系U87先用CFTRinh-172 （5µM）预处理30min，再用Forskolin（50µM）处理48h。CFTRinh-172显著提高了细胞活力和细胞密度，同时部分恢复了Forskolin对U87细胞活力和细胞密度的抑制作用。CFTRinh-172预处理部分减弱了Forskolin对Ki67阳性率的影响，并显著增加了细胞集落形成数目[4]。CCRF-CEM、Jurkat和MOLT-4 T-ALL细胞系经CFTRinh-172（5–40μM）处理24h或48h。CFTRinh-172呈浓度依赖性地抑制所有三种T-ALL细胞系生长并阻断细胞周期。CCRF-CEM、JURKAT和MOLT-4细胞经20μM CFTRinh-172处理24h后，显著改变涉及多种信号通路(包括Wnt/TGF-β信号通路、细胞周期、凋亡过程、细胞增殖、程序性细胞死亡等)的基因表达[5]。
体内实验中，大肠杆菌诱导的急性肺炎症小鼠模型经腹腔给予CFTRinh-172（3mg/kg），CFTRinh-172抑制CFTR加剧了大肠杆菌诱导的急性肺炎症，CFTRinh-172诱导的CFTR缺失促进了大肠杆菌肺炎和腹膜炎小鼠模型中单核细胞和中性粒细胞的迁移[6]。LPS诱导的急性肺损伤大鼠模型经CFTRinh-172治疗后，再静脉给予脂氧素A4（2µM/kg），通过注射泵以0.08mL/min的速度经气管灌注1.5mL（5mL/kg）含CFTRinh-172（1µM）的灌注液。脂氧素A4显著改善LPS诱导肺损伤大鼠的肺组织学表现并抑制IL-6和TNF-α，CFTRinh-172则消除了脂氧素A4对肺泡液体清除（AFC）的作用[7]。
| Cell experiment [1]: | |
Cell lines | T-cell acute lymphoblastic leukemia CCRF-CEM, Jurkat and MOLT-4 cells |
Preparation Method | T-cell acute lymphoblastic leukemia CCRF-CEM, Jurkat and MOLT-4 cells were incubated in CFTRinh-172 wih the concentrations ranged from 5 to 40μM for 24h and 48h. |
Reaction Conditions | 5 to 40μM; 24h and 48h |
Applications | CFTRinh-172 concentration-dependent inhibited the growth of all three T-ALL cell lines. The IC50 ranged from 7 to 15μM in these cells. |
| Animal experiment [2]: | |
Animal models | Male Sprague-Dawley rats |
Preparation Method | The rats were divided into four groups: (1) control group, in which the rats were treated with 0.1% ethanol (vehicle for lipoxin A4) (5mL/kg; iv) 6h after they were treated with 0.9% saline (vehicle for LPS) (4mL/kg; iv); (2) LPS group was identical to the control group except that LPS (20mg/kg; iv) was administered instead of its vehicle; (3) lipoxin A4 treatment group was identical to the LPS group except that lipoxin A4 (2µM/kg; iv) was administered instead of its vehicle; (4) CFTRinh-172 group was identical to the lipoxin A4 treatment group, but 1.5mL of CFTRinh-172 solution (1µM; tracheal instillation) was administered after lipoxin A4. |
Dosage form | 1.5mL of 1µM; tracheal instillation; administration once |
Applications | Treatment of rats with lipoxin A4 significantly inhibited IL-6, TNF-α production and increased alveolar fluid clearance with the outcome of decreased pulmonary edema in lung tissue and CFTRinh-172 was able to abolish the beneficial effects of lipoxin A4. |
References: | |
| Cas No. | 307510-92-5 | SDF | |
| 别名 | CFTR(inh)172, Cystic Fibrosis Transmembrane Conductance Regulator Inhibitor 172 | ||
| 化学名 | 4-[(E)-[4-oxo-2-sulfanylidene-3-[3-(trifluoromethyl)phenyl]-1,3-thiazolidin-5-ylidene]methyl]benzoic acid | ||
| Canonical SMILES | C1=CC(=CC(=C1)N2C(=O)C(=CC3=CC=C(C=C3)C(=O)O)SC2=S)C(F)(F)F | ||
| 分子式 | C18H10F3NO3S2 | 分子量 | 409.4 |
| 溶解度 | ≥ 40.9mg/mL in DMSO | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 2.4426 mL | 12.213 mL | 24.426 mL |
| 5 mM | 0.4885 mL | 2.4426 mL | 4.8852 mL |
| 10 mM | 0.2443 mL | 1.2213 mL | 2.4426 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet